Rankings
▼
Calendar
RGEN Q1 2023 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
Q1 2023 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$165M
-19.9% YoY
Gross Profit
$84M
50.5% margin
Operating Income
$14M
8.4% margin
Net Income
$15M
9.3% margin
EPS (Diluted)
$0.51
QoQ Revenue Growth
-11.4%
Cash Flow
Operating Cash Flow
$11M
Free Cash Flow
$2M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$2.5B
Total Liabilities
$598M
Stockholders' Equity
$1.9B
Cash & Equivalents
$517M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$165M
$206M
-19.9%
Gross Profit
$84M
$124M
-32.7%
Operating Income
$14M
$60M
-76.9%
Net Income
$15M
$47M
-67.3%
Revenue Segments
Product
$183M
100%
Royalty
$39,000
0%
← FY 2023
All Quarters
Q2 2023 →